...in the round by new investor Virtus Inspire Venture and existing investors NantKwest Inc. (NASDAQ:NK), Latterell Venture Partners...

...in the round by new investor Virtus Inspire Venture and existing investors NantKwest Inc. (NASDAQ:NK), Latterell Venture Partners...

...New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners, LVP...

...New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners, LVP...

...New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners, LVP...

...an undisclosed amount in the first closing of a series B round in April 2017; Latterell Venture Partners...
...HDAC Epstein-Barr virus (EBV)-positive lymphoma Phase I complete $18.4 (A) Forward Ventures; NantKwest Inc. (NASDAQ:NK); Latterell Venture Partners...

...Inc. (NASDAQ:NK) took another step toward bolstering its natural killer cell therapy arsenal. Wicklow Capital, Latterell Venture Partners...

...B round led by new investor NantKwest Inc. New investor Wicklow Capital and existing investors Latterell Venture Partners...

...round led by new investor NantKwest Inc. (NASDAQ:NK). New investor Wicklow Capital and existing investors Latterell Venture Partners...

...Leaf Venture Partners, Frazier Healthcare Partners , Longitude Capital, Osage University Partners, Adams Street Partners, LVP...